Testing effectiveness (Phase 2)UnknownNCT01603108What this trial is testingRifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver TransplantWho this might be right forHepatitis C Columbia University 59
Post-approval studies (Phase 4)Study completedNCT00881582What this trial is testingPeginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant PatientsWho this might be right forChronic Hepatitis CRenal Transplant King Abdulaziz Medical City 32
Large-scale testing (Phase 3)Ended earlyNCT02478229What this trial is testingEarly Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)Who this might be right forHepatitis C Viral Infection University Health Network, Toronto 1
Post-approval studies (Phase 4)Study completedNCT02902120What this trial is testingHCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal TransplantWho this might be right forHepatitis CRenal Insufficiency, ChronicDisorder of Transplanted Kidney University of Maryland, Baltimore 21
Post-approval studies (Phase 4)Ended earlyNCT00260208What this trial is testingLiver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or TacrolimusWho this might be right forLiver TransplantHepatitis C Novartis Pharmaceuticals 361
Testing effectiveness (Phase 2)Study completedNCT00668369What this trial is testingEffect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver TransplantationWho this might be right forHepatitis C Virus InfectionLiver Transplantation Hospital Clinic of Barcelona 34
Testing effectiveness (Phase 2)Study completedNCT01938625What this trial is testingPharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver TransplantationWho this might be right forHepatitis C, Chronic Janssen R&D Ireland 35
Large-scale testing (Phase 3)Study completedNCT01571583What this trial is testingAn Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver TransplantationWho this might be right forChronic Hepatitis C Virus (HCV) Infection Janssen-Cilag International NV 74
Not applicableEnrolling By InvitationNCT02422875What this trial is testingComparative Autoantibody and Immunologic Cell Marker StudyWho this might be right forAutoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases Emory University 2,500
Testing effectiveness (Phase 2)Study completedNCT02138253What this trial is testingA Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCVWho this might be right forLiver FibrosisHepatic FibrosisLiver Cirrhosis+1 more Conatus Pharmaceuticals Inc. 64
Large-scale testing (Phase 3)Study completedNCT00151580What this trial is testingTreatment of Recurrent Hepatitis C After Liver TransplantationWho this might be right forLiver TransplantationHepatitis C Rennes University Hospital 200
Not applicableStudy completedNCT00170131What this trial is testingMMF Influence on HCV Viral Evolution After Liver TransplantationWho this might be right forHCV InfectionLiver Transplantation Mayo Clinic 17
Post-approval studies (Phase 4)Study completedNCT02533934What this trial is testingSofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver TransplantWho this might be right forHIVHepatitis CCirrhosis University of California, San Francisco 68
Not applicableUnknownNCT00638144What this trial is testingPrevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis CWho this might be right forHepatitis C University Hospital, Strasbourg, France 300
Testing effectiveness (Phase 2)Study completedNCT03523871What this trial is testingThe Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With MavyretWho this might be right forHepatitis C NYU Langone Health 20
Post-approval studies (Phase 4)Study completedNCT03619837What this trial is testingPrevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney TransplantWho this might be right forHepatitis CTransplantation Disease Transmission University of California, San Francisco 122
Post-approval studies (Phase 4)Study completedNCT00821587What this trial is testingCyclosporine in Hepatitis C Infection Viral Clearance Following Liver TransplantationWho this might be right forHepatitis C University of Florida 39
Large-scale testing (Phase 3)Study completedNCT00469131What this trial is testingEffects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + SteroidWho this might be right forHepatitis CLiver Cirrhosis Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79
Large-scale testing (Phase 3)Study completedNCT01707849What this trial is testingThe Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationWho this might be right forHepatitis C Recurrence After Liver Transplant Hospital Vall d'Hebron 18
Post-approval studies (Phase 4)Study completedNCT00538265What this trial is testingBenefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver TransplantationWho this might be right forLiver Transplantation University Hospital, Toulouse 100